Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for LivaNova (LIVN) over the last 11 years, with Q3 2025 value amounting to $1.1 million.

  • LivaNova's Gains from Investment Securities changed N/A to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 2234.51%. This contributed to the annual value of $15.9 million for FY2024, which is 7000.0% up from last year.
  • Per LivaNova's latest filing, its Gains from Investment Securities stood at $1.1 million for Q3 2025.
  • In the past 5 years, LivaNova's Gains from Investment Securities registered a high of $11.2 million during Q2 2021, and its lowest value of -$31.3 million during Q4 2021.
  • Its 5-year average for Gains from Investment Securities is -$730277.8, with a median of $1.7 million in 2023.
  • In the last 5 years, LivaNova's Gains from Investment Securities plummeted by 65763.05% in 2022 and then soared by 23154.33% in 2024.
  • Over the past 5 years, LivaNova's Gains from Investment Securities (Quarter) stood at -$31.3 million in 2021, then skyrocketed by 110.98% to $3.4 million in 2022, then tumbled by 31.29% to $2.4 million in 2023, then surged by 231.54% to $7.8 million in 2024, then tumbled by 85.82% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $3.0 million for Q2 2025, and $922000.0 during Q1 2025.